Non-remission AML
Showing 1 - 25 of >10,000
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Acute Myeloid Leukemia (AML) Trial in Hershey (Pevonedistat, transplant, Azacitidine)
Terminated
- Acute Myeloid Leukemia (AML)
- Pevonedistat
- +2 more
-
Hershey, PennsylvaniaPenn State Hershey Medical Center: Penn State Cancer Institute
Nov 22, 2020
Leukemia Trial (biological, drug, procedure, radiation)
Active, not recruiting
- Leukemia
- aldesleukin
- +9 more
- (no location specified)
Feb 17, 2022
Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,
Recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)
Recruiting
- Acute Myeloid Leukemia
- Venclexta 100 MG Oral Tablet
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023
Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Azacitidine
- +2 more
-
Suzhou, Jiangsu, China
- +1 more
Aug 18, 2022
AML Patients After Stem Cell Transplant to Understand Relapse
Recruiting
- Acute Myeloid Leukemia in Remission
- Prospective determination of the clinical utility of measurable residual disease (MRD) testing
-
Duarte, California
- +3 more
Dec 7, 2022
Acute Myeloid Leukemia Trial in Germany (HAM, LDAC and/or Mitoxantrone)
Completed
- Acute Myeloid Leukemia
- HAM
- LDAC and/or Mitoxantrone
-
Heidelberg, Baden-Wuerttemberg, Germany
- +17 more
Aug 2, 2022
Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)
Recruiting
- Acute Myelogenous Leukemia
- DC/AML Fusion Vaccine
- Observation
-
Atlanta, Georgia
- +4 more
Apr 14, 2022
Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)
Active, not recruiting
- Acute Myelogenous Leukemia
- AML
- DC AML Vaccine
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 25, 2022
Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)
Recruiting
- Myeloid Malignancies
- fractionated busulfan-based conditioning regimen
-
Chendu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 29, 2023
Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)
Not yet recruiting
- Non-radiographic Axial Spondyloarthritis
- Secukinumab
- Placebo
- (no location specified)
Nov 16, 2022
Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)
Completed
- Acute Myeloid Leukemia
- +2 more
- Fludarabine
- +3 more
-
Milano, Lombardia, ItalyOspedale San Raffaele
Jul 18, 2022
Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker
Completed
- Alkylating Agent-Related Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia
- Laboratory Biomarker Analysis
- Lenalidomide
-
Houston, TexasM D Anderson Cancer Center
Oct 18, 2022
Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)
Recruiting
- Acute Myeloid Leukemia
- Decitabine and Cedazuridine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
AML Trial in Moscow (allo-HSCT)
Recruiting
- AML
- allo-HSCT
-
Moscow, Russian FederationNational Research Center for Hematology
Apr 14, 2022
Acute Myeloid Leukemia in Remission Trial in Nanjing (Azacitidine, Lenalidomide)
Recruiting
- Acute Myeloid Leukemia in Remission
-
Nanjing, Jiangsu, ChinaDepartment of Hematology, Zhongda Hospital Southeast University,
Mar 23, 2022
Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)
Not yet recruiting
- Acute Myeloid Leukemia in Remission
- Fludarabine
- +3 more
-
Nantes, Loire Atlantique, France
- +22 more
Jun 15, 2023
3TR Asthma Biologics Cohort (ABC) Study
Recruiting
- Severe Asthma
-
Copenhagen, Denmark
- +1 more
Nov 6, 2023
MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,
Recruiting
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia
- CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
- Standard of Care Chemotherapy
-
Tampa, FloridaMoffitt Cancer Center
Sep 27, 2022
Acute Myeloid Leukemia (AML) in Remission Trial in Washington (CPX-351)
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
May 3, 2022
Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid
Recruiting
- Acute Lymphoblastic Leukemia (ALL) in Partial Remission
- +2 more
- Cyclophosphamide 50mg
- Methotrexate
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Center
Apr 4, 2022
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under
Active, not recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +3 more
- Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Jan 10, 2022